Pfizer’s PADCEV Keytruda Priority Review Tests Bladder Cancer And Valuation Story

Pfizer (NYSE:PFE) received U.S. FDA Priority Review for a supplemental Biologics License Application covering PADCEV plus ...
Cochrane

What are the effects of removing more lymph nodes (extended dissection) compared to standard lymph node removal in people having their whole bladder removed for bladder cancer?

When the bladder is surgically removed (an operation called radical cystectomy) to treat bladder cancer, surgeons also remove nearby lymph nodes, small glands that are part of the immune system. This ...
Morningstar

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

In the Phase 3 EV-304 trial, statistically significant improvements in overall survival and pathological complete response were also observed, with over half of patients having no detectable disease ...
CURE

FDA Priority Review for Padcev Combo in Bladder Cancer

FDA grants Priority Review for Padcev plus Keytruda in muscle-invasive bladder cancer, showing improved survival and reduced ...

Running Influencer, 45, Dies of Cancer 3 Days After Getting Married

Eugene Lim, who inspired thousands in the running community, was diagnosed with stage 4 bladder cancer in 2024 ...
Seeking Alpha

KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) Reduced Risk of Event-Free Survival Events by 47% and Risk of Death by 35% for Cisplatin-Eligible Patients ...

Late-breaking results from the Phase 3 KEYNOTE-B15 trial were selected for the official Press Program and will be presented at the 2026 American Society of Clinical Oncology (ASCO) Genitourinary (GU) ...
CNA

Doctors warn of hidden cancer risks but caution against excessive or unproven tests

Doctors are urging the public to seek medical advice when abnormal symptoms arise, following the death of local marathoner ...